Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
20.56
+1.43 (7.48%)
Nov 11, 2026, 1:51 PM EST - Market open
Hims & Hers Health Revenue
Hims & Hers Health had revenue of $890.37M in the quarter ending September 30, 2026, with 48.65% growth. This brings the company's total for the last twelve months to $2.87B, up 29.79% year-over-year. In the year 2025, Hims & Hers Health had annual revenue of $2.35B with 59.00% growth. That makes Hims & Hers Health the 3,945th largest company in the world by revenue and 1,078th in the United States.
Revenue (ttm)
$2.87B
Revenue Growth
+29.79%
P/S Ratio
1.62
Revenue / Employee
$1,175,065
Employees
2,442
Market Cap
4.82B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Hims & Hers Health breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.35B | 871.12M | 59.00% |
| Dec 31, 2024 | 1.48B | 604.51M | 69.33% |
| Dec 31, 2023 | 872.00M | 345.08M | 65.49% |
| Dec 31, 2022 | 526.92M | 255.04M | 93.81% |
| Dec 31, 2021 | 271.88M | 123.12M | 82.77% |
| Dec 31, 2020 | 148.76M | 66.20M | 80.18% |
| Dec 31, 2019 | 82.56M | 55.88M | 209.45% |
| Dec 31, 2018 | 26.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bausch Health Companies | 11.11B |
| Dr. Reddy's Laboratories | 3.44B |
| Amneal Pharmaceuticals | 3.20B |
| Alkermes | 1.75B |
| Lantheus Holdings | 1.56B |
| Supernus | 1.37B |
| Kiniksa Pharmaceuticals International, | 945.96M |
| Liquidia | 450.91M |
HIMS News
- 9 hours ago - Hims & Hers Health Faces Legal Woes as Five States Join FTC Lawsuit over Privacy Practices - TipRanks
- 1 day ago - Hims & Hers falls -18.6% - TheFly
- 1 day ago - Hims & Hers (HIMS) Needs Better Profits to Justify Its Price - TipRanks
- 1 day ago - Nvidia, Hims & Hers, JBS, Take-Two, and More Stocks That Explain Today's Market - Barrons
- 1 day ago - Hims & Hers Health Earnings Call Transcript: Q3 2026 - Transcripts
- 1 day ago - Hims & Hers Health Earnings release: Q3 2026 - Filings
- 1 day ago - Hims & Hers Health Quarterly report: Q3 2026 - Filings
- 1 day ago - Hims & Hers Narrows Sales Outlook - WSJ